Clinical trial sites often open and close rapidly, with 60% ceasing operations within the first year, impacting patient ...
Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...
CRD-750 is the first clinical-stage PDE9 inhibitor to be evaluated in patients in both types of chronic heart failure The CYCLE-1-REF trial is evaluating patients with heart failure with reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback